Poly Medicure Limited (POLYMED) - Total Assets
Based on the latest financial reports, Poly Medicure Limited (POLYMED) holds total assets worth Rs35.87 Billion INR (≈ $387.94 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See POLYMED book value for net asset value and shareholders' equity analysis.
Poly Medicure Limited - Total Assets Trend (2006–2025)
This chart illustrates how Poly Medicure Limited's total assets have evolved over time, based on quarterly financial data.
Poly Medicure Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Poly Medicure Limited's total assets of Rs35.87 Billion consist of 60.1% current assets and 40.0% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs1.43 Billion | 4.7% |
| Accounts Receivable | Rs3.50 Billion | 11.0% |
| Inventory | Rs2.86 Billion | 9.0% |
| Property, Plant & Equipment | Rs11.30 Billion | 35.4% |
| Intangible Assets | Rs266.14 Million | 0.8% |
| Goodwill | Rs285.81 Million | 0.9% |
Asset Composition Trend (2006–2025)
This chart illustrates how Poly Medicure Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see POLYMED market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Poly Medicure Limited's current assets represent 60.1% of total assets in 2025, an increase from 34.0% in 2006.
- Cash Position: Cash and equivalents constituted 4.7% of total assets in 2025, up from 0.4% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 16.0% in 2006.
- Asset Diversification: The largest asset category is property, plant & equipment at 35.4% of total assets.
Poly Medicure Limited Competitors by Total Assets
Key competitors of Poly Medicure Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.14 Billion |
|
Vizionfocus Inc.
TW:4771
|
Taiwan | NT$6.53 Billion |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.32 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$272.48 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
Poly Medicure Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.89 | 4.61 | 1.69 |
| Quick Ratio | 3.19 | 3.97 | 1.12 |
| Cash Ratio | 0.31 | 0.43 | 0.00 |
| Working Capital | Rs14.46 Billion | Rs15.07 Billion | Rs1.40 Billion |
Poly Medicure Limited - Advanced Valuation Insights
This section examines the relationship between Poly Medicure Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.63 |
| Latest Market Cap to Assets Ratio | 0.05 |
| Asset Growth Rate (YoY) | 71.8% |
| Total Assets | Rs31.92 Billion |
| Market Capitalization | $1.66 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Poly Medicure Limited's assets below their book value (0.05x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Poly Medicure Limited's assets grew by 71.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Poly Medicure Limited (2006–2025)
The table below shows the annual total assets of Poly Medicure Limited from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | Rs31.92 Billion ≈ $345.25 Million |
+71.76% |
| 2024-03-31 | Rs18.59 Billion ≈ $201.01 Million |
+17.85% |
| 2023-03-31 | Rs15.77 Billion ≈ $170.57 Million |
+14.55% |
| 2022-03-31 | Rs13.77 Billion ≈ $148.90 Million |
+12.51% |
| 2021-03-31 | Rs12.24 Billion ≈ $132.34 Million |
+59.48% |
| 2020-03-31 | Rs7.67 Billion ≈ $82.98 Million |
+17.34% |
| 2019-03-31 | Rs6.54 Billion ≈ $70.72 Million |
+15.78% |
| 2018-03-31 | Rs5.65 Billion ≈ $61.08 Million |
+24.25% |
| 2017-03-31 | Rs4.55 Billion ≈ $49.16 Million |
+17.49% |
| 2016-03-31 | Rs3.87 Billion ≈ $41.84 Million |
+6.29% |
| 2015-03-31 | Rs3.64 Billion ≈ $39.37 Million |
+27.30% |
| 2014-03-31 | Rs2.86 Billion ≈ $30.92 Million |
+33.32% |
| 2013-03-31 | Rs2.14 Billion ≈ $23.20 Million |
+18.01% |
| 2012-03-31 | Rs1.82 Billion ≈ $19.66 Million |
+18.85% |
| 2011-03-31 | Rs1.53 Billion ≈ $16.54 Million |
+20.73% |
| 2010-03-31 | Rs1.27 Billion ≈ $13.70 Million |
+18.91% |
| 2009-03-31 | Rs1.07 Billion ≈ $11.52 Million |
+9.86% |
| 2008-03-31 | Rs969.55 Million ≈ $10.49 Million |
+21.44% |
| 2007-03-31 | Rs798.41 Million ≈ $8.63 Million |
+39.41% |
| 2006-03-31 | Rs572.69 Million ≈ $6.19 Million |
-- |
About Poly Medicure Limited
Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; crit… Read more